Science Explorer Back to mapMap
Discussion
Researcher · Centre Georges François Leclerc · France

Romain Boidot

Romain Boidot publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Immunotherapy and Immune Responses.

ORCID 0000-0001-9956-1737 OpenAlex
World rank
#463,283
of 7,710,434 ranked researchers
Rank in France
#24,580
of 324,115
Works
352
Citations
7.6k
Citations per work
21.5
h-index
42
i10-index 98Top 5.7% in Oncology
Romain Boidot

What does Romain Boidot research?

Romain Boidot's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (31%), Immunology and Microbiology (14%).

Life Sciences: 162 works · 46.1% of their workBiochemistry, Genetics and Molecular Biology: 114 works · 32.5% of their workMolecular Biology: 56 works · 15.9% of their workCancer Research: 40 works · 11.4% of their workGenetics: 18 works · 5.2% of their workImmunology and Microbiology: 48 works · 13.6% of their workImmunology: 48 works · 13.6% of their workHealth Sciences: 109 works · 30.9% of their workMedicine: 109 works · 30.9% of their workOncology: 74 works · 21.1% of their workPulmonary and Respiratory Medicine: 34 works · 9.8% of their workEverything else: 81 works · 23.0% of their workTHEIR WORKRomain Boidot352works
Life Sciences46%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology11432.5%
    2. Immunology and Microbiology4813.6%
    1. Medicine10930.9%
  3. Everything else8123.0%
  1. 1Oncology21% of their works
  2. 2Molecular Biology16% of their works
  3. 3Immunology14% of their works
  4. 4Cancer Research11% of their works
  5. 5Pulmonary and Respiratory Medicine10% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Romain Boidot's research?

The keywords of their largest research topics: Targeted Therapy, Genomic Instability, Immune Checkpoint Blockade, PD-1 and PD-L1, Homologous Recombination, Cancer Genomics, Mutational Signatures and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy512 topics
  2. Genomic Instability482 topics
  3. Immune Checkpoint Blockade461 topic
  4. PD-1 and PD-L1461 topic
  5. Homologous Recombination342 topics
  6. Cancer Genomics321 topic
  7. Mutational Signatures321 topic
  8. Dendritic Cells231 topic
  9. Immunity231 topic
  10. NK Cell Recognition221 topic
  11. Natural Killer Cells221 topic
  12. ALK Inhibitors191 topic
  13. EGFR Mutations191 topic
  14. BRCA Mutation181 topic
  15. PARP Inhibitors181 topic
  16. DNA Damage161 topic
  17. Repair161 topic
  18. BRCA1151 topic
  19. BRCA2151 topic

Where does Romain Boidot work?

Romain Boidot's main affiliation in the publication record is Centre Georges François Leclerc, France.

How many publications and citations does Romain Boidot have?

OpenAlex counts 352 works and 7,562 citations for Romain Boidot, an h-index of 42, ranking #463,283 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Romain Boidot. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.